XAIR - MCAP CO - Beyond Air, Inc.

Beyond Air, Inc. (XAIR) develops compact nitrous oxide synthesis devices, offering clinics a safe alternative to bulky cylinders, which enables the company to maintain premium pricing power. This chart reflects an asset value of 0.00. However, global trade conflicts and issues with Asian electronics could limit exports, while significant marketing expenditures and physician conservatism in the US are temporarily weighing on overall profitability.

Beyond Air, Inc. (XAIR) is developing LungFit technology, expanding its presence in neonatology and the consumables segment. These drivers determine the asset's market value through the product of the current quote and the total number of shares. This metric reflects the real-time aggregate valuation of the business by institutional investors. The indicator's dynamics reveal the stability of capital flows and liquidity risks. By analyzing the company's current market capitalization, one can assess the business's fundamental growth potential.